On the recordDecember 11, 2019
I want to say that we cannot lose sight of how anti-innovation H.R. 3 is. We cannot lose sight of how many cures will never come around as a result. These aren't my conclusions. They are, but they are also the conclusions of the Congressional Budget Office and the Council of Economic Advisers. Hundreds of new drugs will never come to market. Medicines will never be created. We know that 10 percent fewer drugs will enter the market every year in the 2030s and every year thereafter as a result of H.R. 3. This bill will leave people behind. It will result in earlier deaths than otherwise should happen. Mr. Chairman, I yield 1 minute to the gentleman from Virginia (Mr. Griffith).
